AU2208995A - Composition for use in raising an immune response - Google Patents
Composition for use in raising an immune responseInfo
- Publication number
- AU2208995A AU2208995A AU22089/95A AU2208995A AU2208995A AU 2208995 A AU2208995 A AU 2208995A AU 22089/95 A AU22089/95 A AU 22089/95A AU 2208995 A AU2208995 A AU 2208995A AU 2208995 A AU2208995 A AU 2208995A
- Authority
- AU
- Australia
- Prior art keywords
- raising
- composition
- immune response
- immune
- response
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000028993 immune response Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM5004A AUPM500494A0 (en) | 1994-04-12 | 1994-04-12 | Composition for use in increasing mucosal immunity |
AUPM5004 | 1994-04-12 | ||
PCT/AU1995/000206 WO1995027508A1 (en) | 1994-04-12 | 1995-04-12 | Composition for use in raising an immune response |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2208995A true AU2208995A (en) | 1995-10-30 |
Family
ID=3779584
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPM5004A Abandoned AUPM500494A0 (en) | 1994-04-12 | 1994-04-12 | Composition for use in increasing mucosal immunity |
AU22089/95A Abandoned AU2208995A (en) | 1994-04-12 | 1995-04-12 | Composition for use in raising an immune response |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPM5004A Abandoned AUPM500494A0 (en) | 1994-04-12 | 1994-04-12 | Composition for use in increasing mucosal immunity |
Country Status (3)
Country | Link |
---|---|
AU (2) | AUPM500494A0 (en) |
WO (1) | WO1995027508A1 (en) |
ZA (1) | ZA953027B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5919480A (en) * | 1996-06-24 | 1999-07-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Liposomal influenza vaccine composition and method |
US7713942B2 (en) | 2001-04-04 | 2010-05-11 | Nordic Vaccine Technology A/S | Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides |
JP2010514412A (en) | 2006-12-22 | 2010-05-06 | ソリューシオネス バイオテクノロジカス イノヴァシオン リミターダ | DNA fish vaccine |
US8877206B2 (en) * | 2007-03-22 | 2014-11-04 | Pds Biotechnology Corporation | Stimulation of an immune response by cationic lipids |
CA2721366C (en) | 2008-04-17 | 2017-06-06 | Elizabeth Ann Vasievich | Stimulation of an immune response by enantiomers of cationic lipids |
ES2689799T3 (en) * | 2011-09-12 | 2018-11-15 | Pds Biotechnology Corporation | Particulate vaccine formulations |
ES2777935T3 (en) | 2012-06-15 | 2020-08-06 | Pds Biotechnology Corp | Cationic lipid vaccine compositions and procedure for use |
CA2885741C (en) | 2012-09-21 | 2023-10-17 | Frank Bedu-Addo | Vaccine comprising r-dotap |
WO2017083820A1 (en) | 2015-11-13 | 2017-05-18 | Pds Biotechnology Corporation | Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU184141B (en) * | 1979-12-27 | 1984-07-30 | Human Oltoanyagtermelo | Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof |
AU565313B2 (en) * | 1983-10-10 | 1987-09-10 | Biotechnology Australia Proprietary Limited | Vaccine derived from pseudomonas aeruginosa |
SE8405493D0 (en) * | 1984-11-01 | 1984-11-01 | Bror Morein | IMMUNOGENT COMPLEX AND KITCHEN FOR PREPARING IT AND USING IT AS IMMUNOSTIMENTING AGENTS |
EP0231039B1 (en) * | 1986-01-14 | 1992-01-08 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur | Process for preparing immunological complexes and pharmaceutical composition containing these complexes |
NZ230747A (en) * | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
NL9002314A (en) * | 1990-10-23 | 1992-05-18 | Nederlanden Staat | IMMUNOGENE COMPLEXES, IN PARTICULAR ISCOMS. |
CA2126101A1 (en) * | 1991-12-17 | 1993-06-24 | Robert J. Debs | Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
-
1994
- 1994-04-12 AU AUPM5004A patent/AUPM500494A0/en not_active Abandoned
-
1995
- 1995-04-12 ZA ZA953027A patent/ZA953027B/en unknown
- 1995-04-12 WO PCT/AU1995/000206 patent/WO1995027508A1/en active Application Filing
- 1995-04-12 AU AU22089/95A patent/AU2208995A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AUPM500494A0 (en) | 1994-05-05 |
WO1995027508A1 (en) | 1995-10-19 |
ZA953027B (en) | 1996-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1981095A (en) | Seat elevating device | |
AU1716395A (en) | Nutritional composition | |
AU5784994A (en) | Formulation for use in smokers | |
AU1462995A (en) | Backrest device | |
AU3308195A (en) | Antihypertriglyceridemic composition | |
AU1360395A (en) | Low buffer nutritional composition | |
AU3002895A (en) | Compositions for enhancing immune function | |
AU3621895A (en) | Improvements in teats | |
AU2208995A (en) | Composition for use in raising an immune response | |
AU749278C (en) | Composition for use in dementia | |
AU1614495A (en) | Chair | |
AU7997794A (en) | Improvements in connecting means | |
AU641516B2 (en) | Back-rest | |
AU1324795A (en) | Novel feeds for use in aquaculture | |
AU1173892A (en) | Compositions for use in dentistry | |
AU691690B2 (en) | Acrolein-releasing composition and use thereof | |
AU646628B3 (en) | Improvements in birdproofing | |
AU2813195A (en) | Composition | |
AU3291295A (en) | Composition | |
AU2745595A (en) | Easel | |
AU649393B3 (en) | Improvements in chairs | |
AUPM574394A0 (en) | Improvements in piemakers | |
AU6622196A (en) | Composition and its use | |
AU658356B3 (en) | Weighbridge | |
AUPM447694A0 (en) | Antigen composition |